Instrument Inactif

Communiqués ACCM SCIE OTC Markets

Actions

ACMSY

US00442Y1010

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	17/07/23	AQ
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	11/07/23	AQ
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	09/06/23	AQ
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23	AQ
AccuStem Announce Strategic Clinical and Operational Partnership	31/05/23	AQ
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/05/23	AQ
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	02/05/23	AQ
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/02/23	AQ
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	06/12/22	AQ
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22/11/22	AQ
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	16/11/22	AQ
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors	16/11/22	AQ
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	08/11/22	AQ
ACCUSTEM SCIENCES INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	14/10/22	AQ
AccuStem Announces Adjournment of Annual Meeting of Stockholders	10/10/22	AQ
AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer	13/09/22	AQ
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	12/08/22	AQ
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	21/06/22	AQ
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	09/06/22	GL
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20/05/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ACCM SCIE OTC Markets

Actions

ACMSY

US00442Y1010

Communiqués

Filtres